대웅제약
99,100KRWMarket close of 10/27 (Tue)
Down -1.49%-1,500KRWMarket close of 10/27 (Tue)
- Open
- 100,600
- High
- 101,400
- Low
- 98,600
- Day range
- Day range low 98,600 high 101,400, open 100,600, close 99,100, previous close 100,600
- Volume
- 2×10K shares
- 2.2B KRW 1.11× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
0%1-year close range 99,100 to 194,000 won, 0% up from the low
0% of the way up from the lowest close in 1 year (252 sessions) · -48.9% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range-1.49%-1.49%, 0.9× the usual (20-session average ±1.61%)That day -1.49% · usual ±1.61% · large-move threshold ±3.2%
The other 2 are within the usual range
- Trading value1.1×usual range
- EarningsOperating income, 8 quarters
See the full check report
Quarterly results · Q1 2026
- Revenue377.8B KRW
- vs. year ago
- +6.0%
- vs. prior quarter
- -4.9%
- Operating income22.2B KRW
- vs. year ago
- -42.6%
- vs. prior quarter
- -48.8%
- Operating margin5.9%
- vs. year ago
- -5.0 pp
- vs. prior quarter
- -5.0 pp
Quarterly operating income trend
As of the latest official close · 2026-10-27Valuation filing date · 2026-05-15Same sector · 제약
Down -2.22%· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +0.6% | Down -5.37% | 124.5B KRW |
| 셀트리온 | Close over the last 20 sessions +6.3% | Down -0.74% | 82.4B KRW |
| 지투지바이오 | Close over the last 20 sessions +22.2% | Down -13.38% | 46.9B KRW |
| 한미약품 | Close over the last 20 sessions -32.6% | Down -0.57% | 25.5B KRW |
| 에스티팜 | Close over the last 20 sessions -11.9% | Down -9.15% | 21.4B KRW |
Schedule
- Next data 10/29 (Thu) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.